Core Viewpoint - Burning Rock Biotech Limited will hold its annual general meeting (AGM) on December 23, 2025, to discuss key proposals supported by the board of directors [1][2][4]. Group 1: AGM Details - The AGM is scheduled for December 23, 2025, at 10:30 a.m. local time in Shanghai [1]. - The record date for determining shareholders entitled to attend the AGM is December 1, 2025 [3]. - Shareholders holding Class A and Class B ordinary shares are eligible to attend the AGM [3]. Group 2: Proposals for Vote - The proposals include the ratification of Ernst & Young Hua Ming LLP as the auditor for the fiscal year ending December 31, 2025 [8]. - The re-election of directors Feng Deng and Licen Lisa Xu is also on the agenda [8]. - Directors are authorized to take necessary actions to effectuate the proposed resolutions [8]. Group 3: Company Overview - Burning Rock focuses on next generation sequencing (NGS) technology in precision oncology, including therapy selection testing and cancer early detection [6]. - The company has moved its cancer early detection efforts beyond proof-of-concept R&D into clinical validation [6]. Group 4: Financial Reporting - The company has filed its annual report on Form 20-F with complete audited financial statements for the year ended December 31, 2024 [5].
Burning Rock Announces 2025 Annual General Meeting to be Held on December 23, 2025